Search for: "Rachel Sachs" Results 61 - 80 of 106
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
How can the US address coronavirus drug shortages?
7 Apr 2020, 7:34 am by Lisa Larrimore Ouellette
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob SherkowThe escalating pandemic [read post]
Written Description - http://writtendescription.blogspot.com/
Week in Review
24 Sep 2020, 9:05 pm by Joshua Burd
In an article in the Yale Journal on Regulation, Rachel Sachs, a professor at Washington University in [read post]
RegBlog - https://www.theregreview.org/
Weekly Roundup: June 21–27, 2019
28 Jun 2019, 6:07 am
, Swaps, Swaps entities Rent-A-Center: A $1.37 BN Reminder on Reminders Posted by Rachel [read post]
The Harvard Law School Corporate Governance Blog - https://corpgov.law.harvard.edu/
Friday round-up
6 Mar 2015, 7:18 am by Amy Howe
”  At Harvard’s Bill of Health Blog, Rachel Sachs notes that “the Court displayed [read post]
SCOTUSblog - http://www.scotusblog.com/
What can policymakers learn from the UK’s RECOVERY trial to improve clinical research for COVID-19 and beyond?
3 May 2021, 8:36 am by Lisa Larrimore Ouellette
By Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
How is regulatory policy influencing the development and marketing of antibody testing for COVID-19?
4 May 2020, 12:56 pm by Lisa Larrimore Ouellette
By Nicholson Price, Rachel Sachs, Jacob Sherkow, and Lisa Larrimore OuelletteOver the last few weeks, [read post]
Written Description - http://writtendescription.blogspot.com/
How does the law impact the use of 3D printing to address COVID-19 production shortages?
27 Apr 2020, 1:27 pm by Lisa Larrimore Ouellette
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob SherkowHealth systems worldwide [read post]
Written Description - http://writtendescription.blogspot.com/
How does pregnancy factor into COVID-19 innovation?
6 Dec 2021, 6:24 am by Lisa Larrimore Ouellette
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
How does the CDC’s Advisory Committee on Immunization Practices impact innovation and access to COVID-19 vaccines?
27 Aug 2021, 12:18 pm by Lisa Larrimore Ouellette
By Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
How can Congress create infrastructure for the next pandemic?
9 Apr 2021, 8:03 am by Lisa Larrimore Ouellette
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
How can policymakers overcome the hurdles to scaling up antibody manufacturing?
18 Feb 2021, 10:24 am by Lisa Larrimore Ouellette
By Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
What are the innovation challenges to scaling vaccine manufacturing?
10 Sep 2020, 6:23 pm by Lisa Larrimore Ouellette
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
Racial disparities in healthcare innovation in the time of COVID-19
2 Jul 2020, 10:15 am by Lisa Larrimore Ouellette
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
Nonexcludable Innovations and COVID-19
27 May 2020, 12:00 pm by Lisa Larrimore Ouellette
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
IPSC plenary
10 Aug 2018, 5:15 pm by Rebecca Tushnet
/in a group, that might matter v. if it randomizes w/in a group of equally unpopular similar songs.]Rachel [read post]
43(B)log - http://tushnet.blogspot.com/
What administrative actions might we expect on COVID-19 in President-elect Biden’s administration?
30 Nov 2020, 7:24 am by Lisa Larrimore Ouellette
By Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
How are COVID-19 vaccine manufacturers aiming to encourage trust in the FDA’s approval process?
2 Oct 2020, 7:10 am by Lisa Larrimore Ouellette
By Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
How should policymakers use “pull” mechanisms to improve COVID-19 innovation incentives?
30 Jul 2020, 3:39 pm by Lisa Larrimore Ouellette
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
How can policymakers encourage the expansion of at-home diagnostic testing for COVID-19?
2 Jun 2020, 10:31 pm by Lisa Larrimore Ouellette
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
What’s happening with proposals for a WTO waiver of COVID-related IP?
30 Jul 2021, 5:03 am by Lisa Larrimore Ouellette
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/